Targeting complement C5a receptor 2 as a disease-modifying treatment for motor neuron disease [ 1/1/2021 - 12/31/2023 ]

Research Grant

Brief description Motor neuron disease (MND) is a devasting terminal condition that has no effective treatment. We have identified a novel drug which inhibits an immune protein that can potentially treat MND. In this project we will test this drug in rodent models of MND, and validate its effectiveness in relevant MND immune cells. Ultimately, this project will identify a new potential drug for MND.

Funding Amount $636,329

Funding Scheme Development Grants

Chief Investigator A/Pr Trent Woodruff

Notes Development Grant